Your browser doesn't support javascript.
loading
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.
Khan, Aliya A; Rubin, Mishaela R; Schwarz, Peter; Vokes, Tamara; Shoback, Dolores M; Gagnon, Claudia; Palermo, Andrea; Marcocci, Claudio; Clarke, Bart L; Abbott, Lisa G; Hofbauer, Lorenz C; Kohlmeier, Lynn; Pihl, Susanne; An, Xuebei; Eng, Walter Frank; Smith, Alden R; Ukena, Jenny; Sibley, Christopher T; Shu, Aimee D; Rejnmark, Lars.
Affiliation
  • Khan AA; Endocrinology, Metabolism, and Geriatrics, McMaster University, Hamilton, Ontario, Canada.
  • Rubin MR; Endocrinology, Columbia University, New York, New York, USA.
  • Schwarz P; Internal Medicine and Endocrinology, Rigshospitalet, Copenhagen, Denmark.
  • Vokes T; Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, Illinois, USA.
  • Shoback DM; Endocrinology, UCSF/VA Medical Center, San Francisco, California, USA.
  • Gagnon C; CHU de Québec-Université Laval Research Centre and Department of Medicine, Université Laval, Quebec City, Quebec, Canada.
  • Palermo A; Unit of Metabolic Bone and Thyroid Disorders, Fondazione Policlinico Campus Bio-medico, and Unit of Endocrinology and Diabetes, Campus Bio-medico University, Rome, Italy.
  • Marcocci C; Endocrinology, University di Pisa, Pisa, Italy.
  • Clarke BL; Endocrinology, Mayo Clinic E18-A, Rochester, Minnesota, USA.
  • Abbott LG; Northern Nevada Endocrinology, University of Nevada, Reno, Nevada, USA.
  • Hofbauer LC; Endocrinology, Diabetes, and Metabolic Bone Diseases, Technische Universität Dresden Medical Center, Dresden, Germany.
  • Kohlmeier L; Endocrinology, Endocrinology and Spokane Osteoporosis, Spokane, Washington, USA.
  • Pihl S; Biolanalysis and Pharmacokinetics/Pharmacodynamics, Ascendis Pharma A/S, Hellerup, Denmark.
  • An X; Endocrine Medical Sciences, Ascendis Pharma Inc, Palo Alto, California, USA.
  • Eng WF; Endocrine Medical Sciences, Ascendis Pharma Inc, Palo Alto, California, USA.
  • Smith AR; Endocrine Medical Sciences, Ascendis Pharma Inc, Palo Alto, California, USA.
  • Ukena J; Endocrine Medical Sciences, Ascendis Pharma Inc, Palo Alto, California, USA.
  • Sibley CT; Endocrine Medical Sciences, Ascendis Pharma Inc, Palo Alto, California, USA.
  • Shu AD; Endocrine Medical Sciences, Ascendis Pharma Inc, Palo Alto, California, USA.
  • Rejnmark L; Clinical Medicine and Endocrinology, Aarhus University Hospital, Aarhus, Denmark.
J Bone Miner Res ; 38(1): 14-25, 2023 01.
Article in En | MEDLINE | ID: mdl-36271471
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parathyroid Hormone / Hypoparathyroidism Type of study: Clinical_trials / Qualitative_research Aspects: Patient_preference Limits: Humans Language: En Journal: J Bone Miner Res Journal subject: METABOLISMO / ORTOPEDIA Year: 2023 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parathyroid Hormone / Hypoparathyroidism Type of study: Clinical_trials / Qualitative_research Aspects: Patient_preference Limits: Humans Language: En Journal: J Bone Miner Res Journal subject: METABOLISMO / ORTOPEDIA Year: 2023 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos